Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav D Shah

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Journal (Sudbury, Mass.)|July 11, 2007
Adjuvant therapy of melanomaGaurav D Shah, Paul B Chapman
Hematology/Oncology Clinics of North America|August 9, 2005
Treatment of primary central nervous system lymphomaGaurav D Shah, Lisa M DeAngelis
Journal of Neurophysiology|January 11, 2002
Functional role of auditory cortex in frequency processing and pitch perceptionMark Jude Tramo, Gaurav D Shah, Louis D Braida
Cancer|February 4, 2010
Rationale for the development of IMC-3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet-derived growth factor receptor alphaGaurav D Shah, Nick Loizos, Hagop Youssoufian, et al.
Journal of Neuro-Oncology|June 28, 2007
Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomasGaurav D Shah, Joel S Silver, Steven S Rosenfeld, et al.
Neuro-Oncology|January 31, 2006
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomasGaurav D Shah, Santosh Kesari, Ronghui Xu, et al.
Journal of Neuro-Oncology|December 14, 2005
Systemic high-dose intravenous methotrexate for central nervous system metastasesAndrew B Lassman, Lauren E Abrey, Gaurav D Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphomaGaurav D Shah, Joachim Yahalom, Denise D Correa, et al.
Lancet (London, England)|June 14, 2016
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trialWilliam D Tap, Robin L Jones, Brian A Van Tine, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|July 11, 2007
Adjuvant therapy of melanomaGaurav D Shah, Paul B Chapman
Hematology/Oncology Clinics of North America|August 9, 2005
Treatment of primary central nervous system lymphomaGaurav D Shah, Lisa M DeAngelis
Journal of Neurophysiology|January 11, 2002
Functional role of auditory cortex in frequency processing and pitch perceptionMark Jude Tramo, Gaurav D Shah, Louis D Braida
Cancer|February 4, 2010
Rationale for the development of IMC-3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet-derived growth factor receptor alphaGaurav D Shah, Nick Loizos, Hagop Youssoufian, et al.
Journal of Neuro-Oncology|June 28, 2007
Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomasGaurav D Shah, Joel S Silver, Steven S Rosenfeld, et al.
Neuro-Oncology|January 31, 2006
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomasGaurav D Shah, Santosh Kesari, Ronghui Xu, et al.
Journal of Neuro-Oncology|December 14, 2005
Systemic high-dose intravenous methotrexate for central nervous system metastasesAndrew B Lassman, Lauren E Abrey, Gaurav D Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphomaGaurav D Shah, Joachim Yahalom, Denise D Correa, et al.
Lancet (London, England)|June 14, 2016
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trialWilliam D Tap, Robin L Jones, Brian A Van Tine, et al.
Pageof 1